Overview


Deniz Tschammler advises investors, research-based pharmaceutical companies, medical device and medical app manufacturers as well as other players in the German and European health sector in legally complex and strategically significant projects, including transactions and collaborations, disputes in and out of court, market access and reimbursement pathways, competition strategies, and marketing and promotion concepts. Deniz provides legal and strategic background advice in sensitive compliance matters, such as in the area of anti-bribery or data protection, as well as in the context of internal investigations.

Show More

Results


  • Advising a research-based pharmaceutical company in negotiations with the German Federal Ministry of Health concerning the procurement of COVID-19 therapeutics
  • Advising a research-based pharmaceutical company in connection with a cooperation agreement regarding the EU-wide distribution of respiratory drugs
  • Advised a global internet company on telemedical business models in times of the COVID-19 crisis

Show More

Recognitions


  • LMG 2021: Shortlisted for the European Rising Star Award 2020 in Life Sciences
  • The Legal 500 Germany 2021: Recognized as Rising Star in Healthcare and Life Sciences
  • JUVE Handbook 2020/2021: Recognized as Rising Star in Healthcare and Life Sciences (under 40)

Community


  • Research Group on Pharmaceutical Law at the Philipps University of Marburg, Promotion Circle member
  • German-American Lawyers’ Association, member

Credentials


Education
University of St. Gallen, Executive MBA, 2019 to 2021
King’s College London, LLM, 2013
Higher Regional Court of Wiesbaden, Second State Examination, 2012
Philipps University of Marburg, PhD, 2011
Goethe University of Frankfurt, First State Examination, 2008
Universities of Frankfurt and Lyon, Diploma in French Law, 2007

Admissions
Germany

Languages
English
German

 

Dr. Deniz Tschammler

Insights & Events / Media

1

2

3

4